Related Experiment Video
Updated: Mar 21, 2026

06:42
Author Spotlight: Understanding Disease Mechanisms Through Real-Time Analysis of T-Cell Migration
Published on: May 24, 2024
2.4K
Microfluidic-Based Live-Cell Analysis of NK Cell Migration In Vitro
Saravanan Nandagopal1, Francis Lin1,2,3, Sam K P Kung4
1Department of Immunology, University of Manitoba, 417 Apotex Centre, 750 McDermot Avenue, Winnipeg, MB, Canada, R3E 0T5.
Methods in Molecular Biology (Clifton, N.J.)
|May 15, 2016
Summary
This study details a Y-shaped microfluidic device for observing natural killer (NK) cell migration. This method allows for precise, single-cell analysis of NK cell movement in response to chemical signals.
Area of Science:
- Immunology
- Cell Biology
- Biotechnology
Background:
- Natural killer (NK) cell functions are influenced by their microenvironment.
- Understanding NK cell migration is crucial for developing NK cell-based therapies.
- Conventional migration assays lack single-cell resolution and detailed analysis.
Purpose of the Study:
- To describe a microfluidic device method for studying NK cell migration in vitro.
- To enable live-cell imaging and quantitative analysis of NK cell movement.
- To differentiate between chemotaxis, chemokinesis, and chemo-repulsion at the single-cell level.
Main Methods:
- Utilized a Y-shaped microfluidic device for in vitro NK cell migration experiments.
- Employed live-cell imaging to observe NK cell behavior under defined chemical gradients.
- Performed single-cell level analysis of migration parameters like speed and Chemotactic Index.
Main Results:
- The microfluidic device successfully facilitated the study of NK cell migration.
- Quantitative data on single NK cell migration parameters were acquired.
- The method allows for distinguishing different modes of cell migration.
Conclusions:
- Microfluidic devices offer a powerful tool for detailed analysis of NK cell migration.
- This technique provides insights into NK cell behavior within specific microenvironments.
- The described method can advance the development of NK cell-based immunotherapies.

